|
ARL6IP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.095450E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.144370E-03 |
| Normal-vs-Stage2 |
6.858100E-02 |
| Normal-vs-Stage3 |
3.678100E-03 |
| Normal-vs-Stage4 |
6.379300E-04 |
| Stage1-vs-Stage2 |
4.833600E-01 |
| Stage1-vs-Stage3 |
8.549400E-01 |
| Stage1-vs-Stage4 |
3.459600E-01 |
| Stage2-vs-Stage3 |
4.848200E-01 |
| Stage2-vs-Stage4 |
2.245400E-01 |
| Stage3-vs-Stage4 |
4.941600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.019380E-03 |
| Normal-vs-AfricanAmerican |
2.218800E-01 |
| Normal-vs-Asian |
1.129670E-02 |
| Caucasian-vs-AfricanAmerican |
3.589600E-01 |
| Caucasian-vs-Asian |
8.453200E-01 |
| AfricanAmerican-vs-Asian |
5.096400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.594000E-02 |
| Normal-vs-Female |
3.998600E-04 |
| Male-vs-Female |
1.921220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.839900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.361800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.035100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.151400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.681800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.144200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.127800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.619800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.445000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.163200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.716000E-01 |
| Classical-VS-Follicular |
2.304300E-02 |
| Classical-VS-Other |
7.717400E-01 |
| Classical-VS-Normal |
1.245810E-02 |
| Tall-VS-Follicular |
5.956400E-01 |
| Tall-VS-Other |
8.737000E-01 |
| Tall-VS-Normal |
9.176600E-03 |
| Follicular-VS-Other |
6.755400E-01 |
| Follicular-VS-Normal |
4.642500E-04 |
| Other-VS-Normal |
2.025600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.194460E-04 |
| Normal-vs-N1 |
4.4398000000001E-05 |
| N0-vs-N1 |
2.879000E-01 |
|
|
